Meeting Amwise – a Singapore biotech start up on cancer precision medicine and medical AI

Emily Event News Leave a Comment

In this write up, we feature Sean Huang, Founder of Amwise. This biotech start up is a leading brand in precision medicine to serve the well being of Asia cancer patients. The patented examination technology of Amwise is developed based on Asian genes and can identify the risk of tumor recurrence or metastasis, assisting doctors with second opinions. Amwise aims to …

Moving towards genomics driven precision medicine in Asia

Emily Event News Leave a Comment

Emerging technologies are disrupting every industry, with no exception to  biomedical industry in Asia. Early stage biotech companies including Strand Lifesciences are tapping onto this latest trend to provide innovative tools and strategies to improve how stakeholders work in the industry. Vijay Chandru, Executive Chairman of Strand Lifescience joined us at the 14th BioPharma India, Mumbai on 15-16 November 2016. In case …